Oxycontin

Newark narcotics network supplied OxyContin to Bronx, N.Y., ring

February 4, 2008 -- TRENTON – New Jersey Attorney General Anne Milgram and Criminal Justice Director Gregory A. Paw announced that a mother and son pleaded guilty today to racketeering charges for their roles in a Newark-based narcotics ring that distributed millions of dollars a year in illegal prescription painkillers such as OxyContin.    » read more »

Funding comes from prescription drug plea agreement

November 15, 2007 -- Richmond – Virginia Governor Timothy M. Kaine today announced that the Virginia Prescription Monitoring Program (PMP) will receive $20 million as part of the plea agreement involving the Purdue Frederick Company, Inc. John Brownlee, United States Attorney for the Western District of Virginia, will present the funds at PMP’s annual conference on Nov. 16.    » read more »

October 05, 2007 -- Kentucky Attorney General Greg Stumbo today announced the filing of a lawsuit against Purdue Pharma, the manufacturer of OxyContin, a highly abused narcotic.

The lawsuit alleges that Purdue Pharma misrepresented the risks of using OxyContin and seeks to recover damages suffered state and county governments related to widespread addiction caused by the drug.

(Click here for a copy of the Complaint: http://tinyurl.com/2qyfky)    » read more »

September 28, 2007 -- Oregon Attorney General Hardy Myers today announced that the Department of Justice (DOJ) Medicaid Fraud Control Unit has reached a settlement with the Purdue Frederick Company, Inc., a New York Corporation ("Purdue Frederick") and Purdue Pharma L.P., a Delaware limited partnership ("Purdue") which are associated entities engaged in the manufacture, marketing and distribution of OxyContin, an extended-release form of the painkiller Oxycodone.    » read more »

Settlement resolves civil charges caused by company’s misbranding of OxyContin

September 21, 2007 -- TALLAHASSEE, FL – Florida Attorney General Bill McCollum today announced that his Medicaid Fraud Control Unit has joined a national settlement with the Purdue Frederick Company, Inc., a New York corporation, and Purdue Pharma, L.P. a Delaware Limited Partnership. The companies will pay more than $2 million to the State of Florida to resolve civil claims related to the manufacture, marketing and distribution of OxyContin.    » read more »

September 20, 2007 -- (Boise) - The State of Idaho has recovered $652,130 as a result of a civil settlement involving alleged misbranding of the prescription drug OxyContin, Idaho Attorney General Lawrence Wasden said today. Wasden said his office and the Idaho Department of Health and Welfare Medicaid Division joined in a multi-state settlement with two associated businesses engaged in the manufacture, marketing, and distribution of OxyContin, an extended-release form of Oxycodone.    » read more »

September 18, 2007 -- OLYMPIA – Washington Attorney General Rob McKenna announced today that the state's Medicaid program will be reimbursed nearly $2.7 million as part of a settlement with drug manufacturers Purdue Pharma and Purdue Frederick Company. The settlement stems from allegations the company improperly marketed the pain medication OxyContin to health providers.    » read more »